Proteomedix

Developer of next-generation blood test for prostate cancer

placeSchlieren, Zurich, Switzerland calendar_todayFounded 2010 groups11 employees language proteomedix.com

Innovation

2 patent families — focus: Physics & computing; filing pace active.

YearFilings
20242

Investor mix

5 investors on record; lead investors include Venture Kick, Altos Ventures Management, Zhejiang Nuhui Health Technology.

Investor typeCountShare
Venture capital120%
Angel & family office120%
Accelerator & incubator120%
Other / undisclosed240%
Coming soon